Strong margin expansion claims undercut by execution delays, cash burn

Consolidated revenue ₹2,259.5 Cr declined 5.5% YoY; HSCC drag cited (₹300 Cr foreclosed loss-making project)

Consolidated margin 6.9% OPM, 6.8% NPM — well below standalone 8.77%; margin expansion narrative driven by high-fee PMC + marketing revenue from Bharat Business Park sale

Consolidated PAT ₹158 Cr, +17% YoY (not 32%); standalone overstates underlying cash generation — real estate marketing fees are non-cash until realization

Only ₹2,259.5 Cr revenue in Q1 on ₹127K order book (1.8% quarterly run-rate). MAHAPREIT (₹25K), Supertech, J&K all delayed by 18 mo.–2.5 yrs. Cash fell from ₹6,500 Cr to ₹666 Cr, limiting seed-money capacity

Q1 delivered 6.8% NPM, 6.9% OPM. Redevelopment projects contribute 60% revenue but are lumpy (one-off marketing fees when land is sold), not recurring

Reaffirmed ₹16,000–17,000 Cr (vs prior ₹16,000–18,000 Cr). No change in point estimate; consolidated margin expected 6–6.5% PAT, 6.5–7% EBITDA.

FY28 ₹21,000 Cr (up from prior context), FY29 ₹24,000–25,000 Cr and ₹2,000 Cr PAT. Driven by order book inflows and real estate monetization.

Still targeting ₹50,000–60,000 Cr this fiscal (₹30k GPRA, ₹20k other). But delays in Supertech (Supreme Court appeal resolved), J&K (1.5 yr delay), MAHAPREIT (now Q3–Q4) suggest timing slipping.

Expecting ₹500 Cr from real estate (land, completed inventory, construction WIP) in FY27; Ghitorni revenue deferred to FY29 (post-2 yr construction).

5 GPRA (₹50k Cr) is at Cabinet (PIB cleared). Expected Q2–Q3. Other large state orders also in final. Expect ₹50k–60k Cr this year, ₹1–2 orders this quarter, major ones next quarter.

Yes, margins expanding. Redevelopment + Amrapali are 60% of revenue, high-value PMC. Expect PAT 6–6.5%, EBITDA 6.5–7% minimum going forward.

Both seed money and approvals. J&K self-sustainable; took time for DPR. MAHAPREIT delayed on approvals. We have MOU with HUDCO for seed financing. Arranging capital only for 7 GPRA, Amrapali, DTC. Clients arrange rest.

Business Park tower purchase. Construction-linked plan: only 10% paid upfront, rest as construction milestones over 2 years. Asset appreciated from ₹39.1k to ₹66k per sqft.

Q1 usually slower. HSCC merger and low-margin Maharashtra project foreclosed. Redevelopment projects will ramp Q2 onwards. Execution risk understood; we have backup plans.

GRAP accounted for in our ₹16k–17k guidance. We've delivered similar targets before accounting for all constraints. Confident we'll achieve.

Reaffirmed from prior calls. Standalone ₹13,000–14,000 Cr. Hinges on ₹50k–60k order inflows and redevelopment project ramp.

Assumes ₹20k–25k Cr awards awarded this fiscal + major project progression. Real estate upside (37-D, Ghitorni presales) not yet reflected.

Highly dependent on Ghitorni handover (2 yrs from now), 37-D sales momentum, Supertech & MAHAPREIT execution ramp.

Driven by redevelopment (high PMC/marketing fee) mix. One-time sales of real estate inflate near-term; underlying recurring PMC margin ~5–6%.

Q1 delivered 6.9% OPM. Upside if GPRA/redevelopment projects accelerate; downside if executed on low-margin PMC orders.

Together worth ₹50k Cr. MAHAPREIT delayed 18+ months (now Q3–Q4); Supertech awaiting Supreme Court clarity; J&K DPR took 1.5–2 yrs. Block ₹50k–60k order inflow guidance.

₹127k order book, only ₹2.26k Cr Q1 revenue (1.8% quarterly run-rate). To hit ₹16k–17k annual, need ₹4k–4.2k/qtr. Q1 shortfall signals execution bottleneck or lumpiness. If Q2–Q4 don't ramp proportionally, FY27 target at risk.

Cash fell from ₹6,500 Cr (Q4) to ₹666 Cr (Q1)—90% drop. Reason: tower purchase (₹10% upfront, rest construction-linked over 2 yrs). Limits ability to arrange seed capital for new projects (MAHAPREIT, Naveen Nagpur, etc.). Already HUDCO-dependent.

Anti-pollution GRAP rules impose construction freeze in Delhi/NCR Nov–Jan. Redevelopment (GPRA, Amrapali, etc.) and Netaji Nagar are all Delhi-based. Q3 revenue will compress if projects don't complete pre-ban or restart post-ban.

Ghitorni (largest real estate asset, est. ₹2k+ Cr potential) revenue only post-2 yr construction; won't contribute until FY29. 37-D presales start Q2–Q3 but revenue in FY28. This limits near-term PAT upside vs long-term guidance.